Urea Cycle Activation Triggered by Host–Microbiota Maladaptation Driving Colorectal Tumorigenesis
Haoyan Chen(Shanghai Jiao Tong University), Jing‐Yuan Fang(Shanghai Institute of Hematology), Jie Hong(Shanghai Jiao Tong University), Linhua Ji(Shanghai Jiao Tong University), Yile Xie(Shanghai Jiao Tong University), Shiyuan Lu(Second Affiliated Hospital of Zhejiang University), Jinxian Chen(Nanjing Agricultural University), Xiao-Xu Leng(Shanghai Jiao Tong University), Yuqing Yan(Shanghai Jiao Tong University), TaChung Yu, Xiaobo Li(Dalian Ocean University), Tiantian Sun, Xiaoyu Chen(Anhui Medical University), Xinyu Zhang(Shanghai Jiao Tong University), Zheng Wang(Shanghai Jiao Tong University), Licong Zhao(Shanghai University of Traditional Chinese Medicine), Yun Cui(Dalian Institute of Chemical Physics), Yingxuan Chen(Renji Hospital), Tianying Tong(Shanghai Jiao Tong University), Gang Zhao(Shanghai Jiao Tong University), Linhong Song(Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital), Hua Xiong(Shanghai Jiao Tong University), Baoqin Xuan(Shanghai Jiao Tong University)
Cited by 4
Related Papers
Comprehensive review of targeted therapy for colorectal cancer
|Signal Transduction and Targeted Therapy|2020|1.7k
LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc
|Nature Communications|2019|427
Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non–Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry
|Journal of Clinical Oncology|2017|358
Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts
|Nature Communications|2023|231
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
|The Lancet Respiratory Medicine|2021|183